DCA VANTAGE, MODEL 5075

Assay, Glycosylated Hemoglobin

SIEMENS MEDICAL SOLUTIONS DIAGNOSTICS

The following data is part of a premarket notification filed by Siemens Medical Solutions Diagnostics with the FDA for Dca Vantage, Model 5075.

Pre-market Notification Details

Device IDK071466
510k NumberK071466
Device Name:DCA VANTAGE, MODEL 5075
ClassificationAssay, Glycosylated Hemoglobin
Applicant SIEMENS MEDICAL SOLUTIONS DIAGNOSTICS 2 EDGEWATER DR. Norwood,  MA  02062
ContactNoor Malki
CorrespondentNoor Malki
SIEMENS MEDICAL SOLUTIONS DIAGNOSTICS 2 EDGEWATER DR. Norwood,  MA  02062
Product CodeLCP  
Subsequent Product CodeCGX
Subsequent Product CodeJIR
CFR Regulation Number864.7470 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeSpecial
3rd Party ReviewedNo
Combination ProductNo
Date Received2007-05-29
Decision Date2007-10-09
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00630414551364 K071466 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.